290 related articles for article (PubMed ID: 27245255)
1. Association between functional SIRT1 polymorphisms and the clinical characteristics of patients with autoimmune thyroid disease.
Sarumaru M; Watanabe M; Inoue N; Hisamoto Y; Morita E; Arakawa Y; Hidaka Y; Iwatani Y
Autoimmunity; 2016 Aug; 49(5):329-37. PubMed ID: 27245255
[TBL] [Abstract][Full Text] [Related]
2. DICER and DROSHA gene expression and polymorphisms in autoimmune thyroid diseases.
Saeki M; Watanabe M; Inoue N; Tokiyoshi E; Takuse Y; Arakawa Y; Hidaka Y; Iwatani Y
Autoimmunity; 2016 Dec; 49(8):514-522. PubMed ID: 27808570
[TBL] [Abstract][Full Text] [Related]
3. Association of the polymorphisms of chemokine genes (IL8, RANTES, MIG, IP10, MCP1 and IL16) with the pathogenesis of autoimmune thyroid diseases.
Akahane M; Watanabe M; Inoue N; Miyahara Y; Arakawa Y; Inoue Y; Katsumata Y; Hidaka Y; Iwatani Y
Autoimmunity; 2016 Aug; 49(5):312-9. PubMed ID: 27245471
[TBL] [Abstract][Full Text] [Related]
4. Functional Polymorphisms of the Type 1 and Type 2 Iodothyronine Deiodinase Genes in Autoimmune Thyroid Diseases.
Inoue N; Watanabe M; Katsumata Y; Ishido N; Hidaka Y; Iwatani Y
Immunol Invest; 2018 Jul; 47(5):534-542. PubMed ID: 29648895
[TBL] [Abstract][Full Text] [Related]
5. The polymorphisms in the thyroid peroxidase gene were associated with the development of autoimmune thyroid disease and the serum levels of anti-thyroid peroxidase antibody.
Tomari S; Watanabe M; Inoue N; Mizuma T; Yamanaka C; Hidaka Y; Iwatani Y
Endocr J; 2017 Oct; 64(10):1025-1032. PubMed ID: 28845025
[TBL] [Abstract][Full Text] [Related]
6. Polymorphism of IL37 gene as a protective factor for autoimmune thyroid disease.
Yan N; Meng S; Song RH; Qin Q; Wang X; Yao Q; Jiang Y; Jiang W; Shi L; Xu J; Zhang J
J Mol Endocrinol; 2015 Dec; 55(3):209-18. PubMed ID: 26373794
[TBL] [Abstract][Full Text] [Related]
7. Association of the polymorphisms in the gene encoding thyroglobulin with the development and prognosis of autoimmune thyroid disease.
Mizuma T; Watanabe M; Inoue N; Arakawa Y; Tomari S; Hidaka Y; Iwatani Y
Autoimmunity; 2017 Sep; 50(6):386-392. PubMed ID: 28675712
[TBL] [Abstract][Full Text] [Related]
8. Association of
Yamamoto M; Watanabe M; Inoue N; Watanabe A; Ozaki H; Ohsaki M; Hidaka Y; Iwatani Y
Immunol Invest; 2020 Feb; 49(1-2):106-119. PubMed ID: 31505972
[TBL] [Abstract][Full Text] [Related]
9. TSHR Gene Polymorphisms in the Enhancer Regions Are Most Strongly Associated with the Development of Graves' Disease, Especially Intractable Disease, and of Hashimoto's Disease.
Fujii A; Inoue N; Watanabe M; Kawakami C; Hidaka Y; Hayashizaki Y; Iwatani Y
Thyroid; 2017 Jan; 27(1):111-119. PubMed ID: 27762730
[TBL] [Abstract][Full Text] [Related]
10. Polymorphisms of CLEC16A region and autoimmune thyroid diseases.
Muhali FS; Cai TT; Zhu JL; Qin Q; Xu J; He ST; Shi XH; Jiang WJ; Xiao L; Li DF; Zhang JA
G3 (Bethesda); 2014 Mar; 4(6):973-7. PubMed ID: 24646814
[TBL] [Abstract][Full Text] [Related]
11. Plasma VEGF-related polymorphisms are implied in autoimmune thyroid diseases.
Zaaber I; Rancier M; Stathopoulou MG; Saleh A; Marmouch H; Masson C; Murray H; Kurth MJ; Lamont J; Fitzgerald P; Mahjoub S; Said K; Bel Hadj Jrad Tensaout B; Mestiri S; Visvikis-Siest S
Autoimmunity; 2016 Jun; 49(4):229-35. PubMed ID: 26955881
[TBL] [Abstract][Full Text] [Related]
12. Gene polymorphisms of VEGF and VEGFR2 are associated with the severity of Hashimoto's disease and the intractability of Graves' disease, respectively.
Okamoto M; Watanabe M; Inoue N; Ogawa K; Hidaka Y; Iwatani Y
Endocr J; 2020 May; 67(5):545-559. PubMed ID: 32074519
[TBL] [Abstract][Full Text] [Related]
13. Polymorphisms and expression of toll-like receptors in autoimmune thyroid diseases.
Inoue N; Katsumata Y; Watanabe M; Ishido N; Manabe Y; Watanabe A; Masutani R; Hidaka Y; Iwatani Y
Autoimmunity; 2017 May; 50(3):182-191. PubMed ID: 28013570
[TBL] [Abstract][Full Text] [Related]
14. Associations between autoimmune thyroid disease prognosis and functional polymorphisms of susceptibility genes, CTLA4, PTPN22, CD40, FCRL3, and ZFAT, previously revealed in genome-wide association studies.
Inoue N; Watanabe M; Yamada H; Takemura K; Hayashi F; Yamakawa N; Akahane M; Shimizuishi Y; Hidaka Y; Iwatani Y
J Clin Immunol; 2012 Dec; 32(6):1243-52. PubMed ID: 22706687
[TBL] [Abstract][Full Text] [Related]
15. Involvement of functional polymorphisms in the TNFA gene in the pathogenesis of autoimmune thyroid diseases and production of anti-thyrotropin receptor antibody.
Inoue N; Watanabe M; Nanba T; Wada M; Akamizu T; Iwatani Y
Clin Exp Immunol; 2009 May; 156(2):199-204. PubMed ID: 19250279
[TBL] [Abstract][Full Text] [Related]
16. The association between rs4684677 T/A polymorphism in preproghrelin gene and predisposition to autoimmune thyroid diseases in children.
Moniuszko A; Wawrusiewicz-Kurylonek N; Bossowska A; Gościk J; Łuczyński W; Głowińska-Olszewska B; Krętowski A; Bossowski A
Autoimmunity; 2015; 48(6):418-22. PubMed ID: 25868387
[TBL] [Abstract][Full Text] [Related]
17. Associations of single nucleotide polymorphisms in precursor-microRNA (miR)-125a and the expression of mature miR-125a with the development and prognosis of autoimmune thyroid diseases.
Inoue Y; Watanabe M; Inoue N; Kagawa T; Shibutani S; Otsu H; Saeki M; Takuse Y; Hidaka Y; Iwatani Y
Clin Exp Immunol; 2014 Nov; 178(2):229-35. PubMed ID: 24990808
[TBL] [Abstract][Full Text] [Related]
18. The functional polymorphisms of VDR, GC and CYP2R1 are involved in the pathogenesis of autoimmune thyroid diseases.
Inoue N; Watanabe M; Ishido N; Katsumata Y; Kagawa T; Hidaka Y; Iwatani Y
Clin Exp Immunol; 2014 Nov; 178(2):262-9. PubMed ID: 25046415
[TBL] [Abstract][Full Text] [Related]
19. Polymorphisms of IKZF3 Gene and Autoimmune Thyroid Diseases: Associated with Graves' Disease but Not with Hashimoto's Thyroiditis.
Li L; Ding X; Wang X; Yao Q; Shao X; An X; Yan N; Jiang Y; Wang W; Shi L; Qin Q; Song R; Zhang JA; Sun P
Cell Physiol Biochem; 2018; 45(5):1787-1796. PubMed ID: 29510406
[TBL] [Abstract][Full Text] [Related]
20. The IL15 +96522 A>T functional polymorphism is related to the differentiation of Th17 cells and the severity of Hashimoto's disease.
Arakawa Y; Watanabe M; Takemura K; Inoue N; Hidaka Y; Iwatani Y
Int J Immunogenet; 2017 Apr; 44(2):41-50. PubMed ID: 28164472
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
